Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 101 results.
User Information
Export Records
  1. 1.   How to recover from a bad start: adaptation of HIV-1 transcription start site mutants during serial passaging in culture
  2. Nikolaitchik,Olga; Chameettachal,Akhil; Islam,Mohammad Saiful; Keele,Brandon; Delviks-Frankenberry, Krista; Pathak,Vinay; Hu,Wei-Shau; Cheng,Zetao
  3. Journal of Virology. 2025, May 07; e0015925.
  1. 2.   Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
  2. Zhang, Liguo; Richards, Alexsia; Barrasa, M Inmaculada; Hughes,Stephen; Young, Richard A; Jaenisch, Rudolf
  3. Proceedings of the National Academy of Sciences of the United States of America. 2021, May 25; 118(21):
  1. 3.   Nuclear Import of the HIV-1 Core Precedes Reverse Transcription and Uncoating
  2. Selyutina, Anastasia; Persaud, Mirjana; Lee,Kyeongeun; KewalRamani,Vineet; Diaz-Griffero, Felipe
  3. Cell reports. 2020, Sep 29; 32(13): 108201.
  1. 4.   Recombination is required for efficient HIV-1 replication and the maintenance of viral genome integrity
  2. Rawson,Jonathan; Nikolaitchik,Olga; Keele,Brandon; Pathak,Vinay; Hu,Wei-Shau
  3. NUCLEIC ACIDS RESEARCH. 2018, Nov 16; 46(20): 10535-10545.
  1. 5.   Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene
  2. Chan, Chi Ngai; Trinite, Benjamin; Levy, David N.
  3. Antimicrobial Agents and Chemotherapy. 2017, Aug 24; 61(9): e00408-17.
  1. 6.   Reverse Transcription in the Saccharomyces cerevisiae Long-Terminal Repeat Retrotransposon Ty3
  2. Rausch, Jason; Miller, Jennifer; Legrice, Stuart
  3. VIRUSES-BASEL. 2017, Mar; 9(3):
  1. 7.   Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.
  2. Post, Klara; Olson, Erik D; Naufer, M Nabuan; Gorelick, Robert J; Rouzina, Ioulia; Williams, Mark C; Musier-Forsyth, Karin; Levin, Judith G
  3. Retrovirology. 2016, Dec 29; 13(1): 89.
  1. 8.   Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA
  2. Abulwerdi, Fardokht; Shortridge, Matthew D.; Sztuba-Solinska, Joanna; Wilson, Robert; Legrice, Stuart; Varani, Gabriele; Schneekloth, Jay
  3. JOURNAL OF MEDICINAL CHEMISTRY. 2016, Dec 22; 59(24): 11148-11160.
  1. 9.   HIV-1 Capsid-Targeting Domain of Cleavage and Polyadenylation Specificity Factor 6
  2. Lee, K.; Mulky, A.; Yuen, W.; Martin, T. D.; Meyerson, N. R.; Choi, L.; Yu, H.; Sawyer, S. L.; KewalRamani, V. N.
  3. Journal of Virology. 2012, Apr; 86(7): 3851-3860.
  1. 10.   The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability
  2. Jiang, J. Y.; Ablan, S. D.; Derebail, S.; Hercik, K.; Soheilian, F.; Thomas, J. A.; Tang, S. X.; Hewlett, I.; Nagashima, K.; Gorelick, R. J.; Freed, E. O.; Levin, J. G.
  3. Virology. 2011, Dec; 421(2): 253-265.
  1. 11.   Femtomole SHAPE Reveals Regulatory Structures in the Authentic XMRV RNA Genome
  2. Grohman, J. K.; Kottegoda, S.; Gorelick, R. J.; Allbritton, N. L.; Weeks, K. M.
  3. Journal of the American Chemical Society. 2011, Dec; 133(50): 20326-20334.
  1. 12.   Diverse interactions of retroviral Gag proteins with RNAs
  2. Rein, A.; Datta, S. A. K.; Jones, C. P.; Musier-Forsyth, K.
  3. Trends in Biochemical Sciences. 2011, Jul; 36(7): 373-380.
  1. 13.   The TY3 Gag3 Spacer Controls Intracellular Condensation and Uncoating
  2. Clemens, K.; Larsen, L.; Zhang, M.; Kuznetsov, Y.; Bilanchone, V.; Randall, A.; Harned, A.; DaSilva, R.; Nagashima, K.; McPherson, A.; Baldi, P.; Sandmeyer, S.
  3. Journal of Virology. 2011, Apr; 85(7): 3055-3066.
  1. 14.   Matrix Domain Modulates HIV-1 Gag's Nucleic Acid Chaperone Activity via Inositol Phosphate Binding
  2. Jones, C. P.; Datta, S. A. K.; Rein, A.; Rouzina, I.; Musier-Forsyth, K.
  3. Journal of Virology. 2011, Feb; 85(4): 1594-1603.
  1. 16.   Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: Biological implications
  2. Wu, T. Y.; Datta, S. A. K.; Mitra, M.; Gorelick, R. J.; Rein, A.; Levin, J. G.
  3. Virology. 2010, Sep; 405(2): 556-567.
  1. 17.   Vif of Feline Immunodeficiency Virus from Domestic Cats Protects against APOBEC3 Restriction Factors from Many Felids
  2. Zielonka, J.; Marino, D.; Hofmann, H.; Yuhki, N.; Lochelt, M.; Munk, C.
  3. Journal of Virology. 2010, Jul; 84(14): 7312-7324.
  1. 18.   APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms
  2. Mbisa, J. L.; Bu, W.; Pathak, V. K.
  3. Journal of Virology. 2010, May; 84(10): 5250-5259.
  1. 19.   Secondary Structure of the Mature Ex Virio Moloney Murine Leukemia Virus Genomic RNA Dimerization Domain
  2. Gherghe, C.; Leonard, C. W.; Gorelick, R. J.; Weeks, K. M.
  3. Journal of Virology. 2010, Jan; 84(2): 898-906.
  1. 20.   C-terminal Domain Modulates the Nucleic Acid Chaperone Activity of Human T-cell Leukemia Virus Type 1 Nucleocapsid Protein via an Electrostatic Mechanism
  2. Qualley, D. F.; Stewart-Maynard, K. M.; Wang, F.; Mitra, M.; Gorelick, R. J.; Rouzina, I.; Williams, M. C.; Musier-Forsyth, K.
  3. Journal of Biological Chemistry. 2010, Jan; 285(1): 295-307.
  1. 21.   APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
  2. Reddy, K.; Winkler, C. A.; Werner, L.; Mlisana, K.; Karim, S. S. A.; Ndung'u, T.; Team, C. A. I. S.
  3. Aids. 2010, Jan; 24(2): 195-204.
  1. 22.   Features, processing states and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function
  2. Mirambeau, G.; Lyonnais, S.; Gorelick, R. J.
  3. Rna Biology. 2010, Nov-Dec; 7(6): 724-734.
  1. 23.   Nucleic acid chaperone activity of retroviral Gag proteins
  2. Rein, A.
  3. Rna Biology. 2010, Nov-Dec; 7(6): 700-705.
  1. 24.   Identification and analysis of novel transcripts and promoters in the human killer cell immunoglobulin-like receptor (KIR) genes
  2. Li, H.; Wright, P. W.; Anderson, S. K.
  3. Methods in molecular biology (Clifton, N.J.). 2010 612: 377-91.
  1. 25.   Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development
  2. Smith, J. L.; Bu, W.; Burdick, R. C.; Pathak, V. K.
  3. Trends in Pharmacological Sciences. 2009, Dec; 30(12): 638-646.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel